Johnson & Johnson (JNJ)
Johnson & Johnson Capital Expenditures: 144.00M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
JNJ Capital Expenditures Rankings
| Overall | 7th percentile | 4103 of 4450 |
| Sector | 1st percentile | 497 of 507 in Healthcare |
| Industry | 19th percentile | 20 of 25 in Drug Manufacturers - Major |
JNJ Capital Expenditures Range, Past 5 Years
| Minimum | 133.00M | Sep 2011 |
| Maximum | 995.00M | Dec 2007 |
| Average | 515.00M |
About Capex
Capital expenditures are a line item from a company's statement of cash flows (click "Learn More" below for details).
Capex (short for capital expenditures) are incurred when a business spends money to purchase fixed assets or to add value to an existing fixed asset. In accounting, a capital expenditures are added to an asset account, thus increasing the value of the asset.
Examples of capital expenditures include the purchase of a new manufacturing plant, investment in server farms for tech companies, or other purchases of assets expected to help the company earn profits in the future.
Unlike other investments like research and development and marketing spending, capital expenditures are not immediately expensed. Rather, property, plant and equipment acquired using capital expenditures are usually expensed over time through the use of depreciation.
Learn More
You may also be interested in these JNJ related companies
JNJ News
Five Stocks Hedge Funds are Betting Against: the Short List from Goldman Sachs http://stks.co/3zh7 $IBM $XOM $INTC $AMZN $JNJ
about 19 hours ago by ycharts
about 19 hours ago by ycharts
Current portfolio: $AAPL $AIG $JNJ $DD looking to add energy name soon
about 2 days ago by WestCoastHedge
about 2 days ago by WestCoastHedge
May 24 Support/resistance numbers for S&P and top components. http://stks.co/3y4b $ES_F $AAPL $XOM $CVX $JNJ $PG $$
about 2 days ago by TripleDTrader
about 2 days ago by TripleDTrader
Former Stryker (SYK) CEO Sends Strong Message to Other Execs: Ask First
May 23, 11:42AM Street Insider
May 23, 11:42AM Street Insider
Ex-Dividend Stocks http://stks.co/3wtm My story via @TheStreet $JNJ $MHP $AIZ $DNB $NDSN $WEP $SIX #Dividend #ExDividend
about 3 days ago by azendrian
about 3 days ago by azendrian
Go into Pharma to avoid the bloodbath in the markets. Rotation into safety $PFE $MRK $JNJ http://stks.co/3tbu
about 8 days ago by EPS_MomentuM
about 8 days ago by EPS_MomentuM
News related to $JNJ, currently 0.0% since open: 'Alkermes takes bigger 4Q loss after Elan deal' http://stks.co/3sOZ
about 9 days ago by TradeBot
about 9 days ago by TradeBot
Stocks trading ex-dividend one week from today: http://stks.co/3rwa $JNJ $AIZ $INTX $MHP $NATL $SIX $STRA ...
about 9 days ago by DynamicDividend
about 9 days ago by DynamicDividend
$STXS raises 18.5M to pay down credit facility and for general corporate purposes http://stks.co/3r3z $JNJ $BSX $HNSN
about 10 days ago by ATandon_STE
about 10 days ago by ATandon_STE
$OSUR fromwith first non-prescription HIV test buyout becomes very real $JNJ $ABT $ROG very nice price here
about 10 days ago by leahcim474
about 10 days ago by leahcim474
Canaccord Genuity Morning Coffee on Avon Products (NYSE: AVP): Even Concealer Can't Fix This Mess
May 16, 10:20AM Street Insider
May 16, 10:20AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| JNJ | 62.51 | -0.59 | -0.94% | 171.61B |
| JMP | 5.86 | -0.12 | -2.01% | 129.27M |
| JLL | 72.24 | +0.06 | +0.08% | 3.152B |
| JKHY | 33.13 | -0.17 | -0.51% | 2.875B |
| JKH | 99.56 | -0.12 | -0.12% | |
| JJSF | 54.90 | -0.25 | -0.45% | 1.032B |
| JHX | 36.15 | -0.32 | -0.87% | 3.148B |
| JHS | 15.64 | -0.11 | -0.70% | |
| LNT | 44.04 | +0.11 | +0.25% | 4.889B |
| LNG | 15.01 | -0.01 | -0.07% | 2.261B |
